 VALENCIA, Calif., Oct. 28, 2020 GLOBE NEWSWIRE -- AVITA Therapeutics, Inc. NASDAQ: RCEL, ASX:AVH, a regenerative medicine company that is developing and commercializing a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs, announced today that management will participate in the following upcoming investor conferences. 